Dermatomyositis - Diagnosis & treatment - Mayo Clinic
WEBJun 30, 2022 · The two most common medications for dermatomyositis are azathioprine (Azasan, Imuran) and methotrexate (Trexall). Mycophenolate mofetil (Cellcept) is another medication used to treat dermatomyositis, particularly if the lungs are involved.
Initial treatment of dermatomyositis and polymyositis in adults
WEBMar 7, 2024 · Society guideline links: Dermatomyositis and polymyositis; Treatment of recurrent and resistant dermatomyositis and polymyositis in adults; Use of methotrexate in the treatment of rheumatoid arthritis
Dermatomyositis - StatPearls - NCBI Bookshelf
WEBAug 7, 2023 · The first-line treatment for dermatomyositis is prednisolone. [Level 5] Level 5] Concomitant treatment with glucocorticoids and immunosuppressants should be given to patients who are resistant to treatment with glucocorticoids alone or have extra muscular complications or severe weakness.
Dermatomyositis: An Acute Flare and Current Treatments
WEBJun 18, 2019 · The treatment of dermatomyositis involves a multidisciplinary approach, as evidenced in this case. When patients are appropriately managed using pharmacologic and nonpharmacologic therapy, the outcome and prognosis are better.
Dermatomyositis: Practical Guidance and Unmet Needs
WEBMar 6, 2024 · Dermatomyositis Treatment. Treatment approaches to DM depend on multiple factors, including presence/severity of myositis, cutaneous lesion type (non-vasculopathic vs vasculopathic), extent of cutaneous involvement, cutaneous symptoms, visceral organ involvement, presence of underlying malignancy, and type of MSA.
Dermatomyositis - Symptoms, diagnosis and treatment | BMJ …
WEBMar 19, 2024 · Initial treatment of muscle disease is with high-dose oral corticosteroids, followed by the addition of immunosuppressants or intravenous immunoglobulin in refractory cases. Skin manifestations are treated with …
Dermatomyositis: An Update on Diagnosis and Treatment
WEBDermatologists should play a crucial role in the diagnosis and management of patients with dermatomyositis as cutaneous disease tends to be chronic, negatively impact quality of life, and be more recalcitrant to therapy. In this review, we discuss diagnosis, with a focus on myositis-specific antibodies and their associated phenotypes.
WEBdiagnosis of DM is made, and treatment recommendations for patients with DM based on disease severity, the presence of systemic symptoms, and myositis-specific antibody (MSA) profiles. This review emphasizes
Diagnosis and differential diagnosis of dermatomyositis and ... - UpToDate
WEBFeb 24, 2022 · Dermatomyositis (DM) and polymyositis (PM) are idiopathic inflammatory myopathies, characterized by the shared features of proximal skeletal muscle weakness and evidence of muscle inflammation [1-5]. DM, unlike PM, is associated with a variety of characteristic skin manifestations.
Cutaneous dermatomyositis in adults: Overview and initial ... - UpToDate
WEBOct 12, 2022 · Skin lesions of DM are often resistant to photoprotection and topical therapies alone, necessitating the initiation of antimalarial drugs and/or methotrexate. Patients who fail to respond to these interventions may require more aggressive immunosuppressive or immunomodulatory therapies.
Skip to content